Pendal Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,567
| Closed | -$1.79M | – | 529 |
|
|
2020
Q3 | $1.79M | Sell |
12,567
-32,833
| -72% | -$4.68M | 0.02% | 189 |
|
|
2020
Q2 | $5.01M | Sell |
45,400
-4,743
| -9% | -$523K | 0.07% | 105 |
|
|
2020
Q1 | $5M | Buy |
50,143
+15,515
| +45% | +$1.55M | 0.09% | 87 |
|
|
2019
Q4 | $5.17M | Buy |
34,628
+14,647
| +73% | +$2.19M | 0.07% | 129 |
|
|
2019
Q3 | $2.56M | Buy |
19,981
+6,359
| +47% | +$815K | 0.03% | 182 |
|
|
2019
Q2 | $1.94M | Buy |
13,622
+2,079
| +18% | +$296K | 0.03% | 218 |
|
|
2019
Q1 | $1.65M | Hold |
11,543
| – | – | 0.02% | 244 |
|
|
2018
Q4 | $1.43M | Buy |
11,543
+3,209
| +39% | +$398K | 0.02% | 236 |
|
|
2018
Q3 | $1.4M | Buy |
8,334
+1,157
| +16% | +$195K | 0.02% | 260 |
|
|
2018
Q2 | $1.24M | Sell |
7,177
-8
| -0.1% | -$1.38K | 0.02% | 281 |
|
|
2018
Q1 | $1.08M | Buy |
7,185
+97
| +1% | +$14.6K | 0.01% | 313 |
|
|
2017
Q4 | $954K | Buy |
7,088
+122
| +2% | +$16.4K | 0.01% | 307 |
|
|
2017
Q3 | $1.02M | Buy |
6,966
+2,777
| +66% | +$406K | 0.01% | 306 |
|
|
2017
Q2 | $651K | Buy |
+4,189
| New | +$651K | 0.01% | 337 |
|